Over the past five years, the cosmetic industry has met with several legislative changes. Within the new legislative package, including the new REACH and CLP, it is important to find a comfortable routine that will minimize costs while staying effective and compliant with all regulations.
Cyborgs – Humans, upgraded! How technology will turn humans into superhumans
Have you heard about cases where someone's online passwords are stolen and misused to gain access into their bank accounts, personal accounts and sensitive data? In this new digital era, when we keep our passwords and PINs saved in our smartphones and PCs, thus stored online, our very identities have become easy prey for hackers.
But have you heard about the tool that makes this crime impossible? Let me introduce to you an implantable NFC chips – platforms for identity, security, cryptography and payment applications. It is a very small, security-oriented computer implanted in the body – under the skin.
These chips allow our biological and digital identity to unite and give us full control of our digital self. Only we decide who can use our data and how, thanks to cryptography that easily proves its us making transactions.
Some of these implants allow developers to create their own applications and then store them on the chip. Over time, besides apps for smartphones and PCs, there will be more and more space created for ever more applications. In particular, payment options, security applications, locking systems, data storage and even activity tracking capabilities can be enabled.
Your chip can neither be stolen nor hacked and you can't lose it. These are the biggest benefits that come along. One doesn't need cash and a debit or credit card anymore and no one can misuse the private data on the Internet.
To see what such a chip can look like and how it is implanted under the skin, watch the videos here.
You can learn more about the implantable chips at the upcoming 4th Annual Open Innovation - Life Science, Pharma & Biotech (17 – 18 November 2016, Vienna).
Dr. Patrick Kramer, Chief Cyborg Officer at Digiwell – Upgrade your life, has a long history of work experience in leading IT and consulting companies like PWC and IBM, and has been working in the areas of Digital Transformation, Performance Management and the Internet-of-Things. Having been a biohacker for many years, in May 2016 he turned his hobby into a startup and founded the biohacking platform Digiwell – Upgrade your life.
In Patrick’s vision, wearables will more and more be worn under the skin. Wearing an implant himself, he experiments with the next-generation of implants in his body: From the Internet-of-Things to the Internet-of-Us, where we all are connected directly to the Internet through brain implants.
At the 4th Annual Open Innovation - Life Science, Pharma & Biotech, Patrick's presentation will focus on Cyborgs as upgraded humans, a topic that provokes and fascinates many people, and introduce us to the fascinating world of smart implants and bodyhackers.
During his speech, he will perform a live chip implantation on stage! This will be a good chance for all who would like to see this or like to get an implant themselves. Attendees will also have a chance to win one of three implants during the event. View your options on how to join the event.
Interested in this topic?
Advanced Protein Aggregation & Characterization
This training will focus on occurrence of particles in drug products, effects of protein aggregates, critical process and parameters. Attendees will gain overview of on utility and limits of predictive experiments, learn concerns from the authorities and relevant aggregation guidelines, and more.
CMC Analytical Comparability: Methods & Strategies for Biologics, Biosimilars & Biobetters
Attendees will be introduced to comparability in biosimilar development, the analytical strategies of protein characterization of biosimilars, the structure of proteins, in vitro pharmacology and much more.
Corporate Compliance & Transparency in the Pharmaceutical Industry
This two-day conference will serve as a platform for an open and dynamic dialogue with HCPs and patients to achieve common goals. Learn how to embed compliance in the business and develop one simple system for managing compliance & transparency in a complex and regulated environment.
Driving the national agenda of Medical tourism through PX Excellence
Read the interview with Dr. Layla Al-Marzouqi, Director of Medical Tourism Council at Dubai Health Authority, and learn how to enrich patient experience and quality of healthcare.
No more trouble with dangerous good shipments
Global temperature controlled pharmaceutical shipments are constantly faced with new logistics challenges and regulations. This January 2017, IATA Dangerous Goods Regulations added further complexity to shipping cold chain products compliantly.
5 Changes in Signal Detection Management
The European Medicines Agency, regulatory authorities in the Member States and marketing authorisation holders are responsible for detecting and managing safety signals. A safety signal is generally defined as information about a new or known Adverse Event that may have been caused by a medicine, where it is therefore necessary to conduct further investigation. Evaluation of safety signals plays a major role within pharmacovigilance. Therefore, it is vital for regulatory authorities to know the latest updates detailing the risks and benefits of medicines. The EudraVigilance database is an important source of information on suspected adverse reactions and signals.